Broadening the reach of mass spec both in and outside the lab with Bruker Acquisition
5 - 9 June 2022
Meet us at booth 509 at ASMS 2022 to learn more about how IonSense’s acquisition by Bruker accelerates DART-MS methods and application development. Also, block out your diary for two keys events; an oral presentation from our Chief Technical Officer, Brian Musselman and a poster presentation from our Application Scientist, William Fatigante.
With DART instruments:
We’re delighted to officially confirm that IonSense has recently been acquired by the Bruker Corporation in a move that will enable us to accelerate the development and reach of our DART-MS technology.
The deal provides us with the financial investments to ramp up development of our DART ionization source technology and increase efforts in developing applications in the applied markets, including food analysis and forensics.
Commenting on the acquisition, our CEO, Jeff Zonderman , said: “Our vision remains to use DART to empower mass spectrometers to perform better outside their traditional LC and GC workflows. We are committed to continuing sales of our DART sources for coupling with all vendors’ mass spectrometers. In partnership with Bruker, we will leverage their strong presence and reputation in analytical instrumentation, and their investments in IonSense, to introduce our enabling technology to a wider customer audience at a faster pace.”
Oral presentation
Date: 06 June
Time: 16:10pm - 16:30pm Room L100
Topic: Direct Liquid Sampling with a Combined DART-Infrared Laser ionization source for Qualitative and Quantitative Analysis of Drugs in Biological Fluids
Delivered by: Brian D Musselman; William L Fatigante; IonSense, Inc., MA
Date: 06 June
Time: 10:30am - 2.30pm poster # MP128
Topic: A DART-MS Technique with SPME that Provides a Rapid Screening Approach to PFAS Analysis
Delivered by: William L Fatigante; Brian D Musselman; IonSense, Inc., MA, Ronald V Emmons; Emanuela Gionfriddo; MA; University of Toledo, OH